Consolidated Statements of Cash Flows - USD ($)	4 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (5,000)	$ (6,864,581)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities		4,795,400
Interest earned on marketable securities held in Trust Account		(21,238)
Transaction costs incurred in connection with IPO		520,319
Payment of formation costs through issuance of Class B ordinary shares	5,000
Changes in operating assets and liabilities:
Prepaid expenses		(208,056)
Accrued expenses		312,942
Net cash used in operating activities		(1,465,214)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(230,000,000)
Net cash used in investing activities		(230,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid		226,000,000
Proceeds from sale of Private Placement Warrants		6,000,000
Advances from related party		870
Refund of over payment of promissory note		25,000
Proceeds from promissory note – related party		60,910
Payments made on promissory note - related party		(155,410)
Payment of offering costs		(374,749)
Net cash provided by financing activities		231,556,621
Net Change in Cash and cash equivalents		91,407
Cash and cash equivalents – Beginning
Cash and cash equivalents– Ending		91,407
Non-cash investing and financing activities:
Payment of offering costs by the Sponsor in exchange for the issuance of Class B ordinary shares	20,000
Payment of offering costs through the issuance of promissory note	69,500
Initial classification of public warrant liability		8,970,000
Initial classification of private warrant liability		4,740,000
Initial classification of Class A ordinary shares subject to possible redemption		230,000,000
Accretion for Class A ordinary shares subject to redemption amount		21,585,168
Deferred underwriting fee payable		$ 8,650,000